Nothing to disclose.
|
|
- Emil Chapman
- 6 years ago
- Views:
Transcription
1 Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1
2 This talk will be a little depressing Rising incidence of many STDs Increasing antibiotic resistance gonorrhea Clusters of complications syphilis Success of PrEP and advances in HIV treatment are positives! CDC 2015 STD surveillance report Total combined cases of chlamydia, gonorrhea, and syphilis reached the highest number ever reported in the U.S. Yet, not that long ago, gonorrhea rates were at historic lows, syphilis was close to elimination, and we were able to point to advances in STD prevention, such as better chlamydia diagnostic tests and more screening, contributing to increases in detection and treatment of chlamydial infections. That progress has since unraveled. Gail Bolan, MD, Director, Division of STD Prevention, CDC, published October 19, 2016 Situation worse in
3 Outline organisms and syndromes Gonorrhea Chlamydia Trichomonas Urethritis Syphilis Genital HSV Emerging STDs Gonorrhea CDC 2016 STD Surveillance Report 3
4 Gonorrhea CDC 2016 STD Surveillance Report Gonorrhea CDC 2016 STD Surveillance Report 4
5 Gonorrhea Second most commonly reported communicable diseases Chief complication in women tubal scarring Infertility and ectopic pregnancy Screening Sexually active women < 25 years annually Women 25 years and older with New sex partner, more than one partner, partner with concurrent partners, partner with STI Sexually active MSM at least annually Urethral, rectal, oropharyngeal depending on sex practices Gonorrhea diagnostic testing Culture and nucleic acid amplification testing (NAAT) NAAT FDA approved for women Endocervical swab Vaginal swab self or clinician collected First catch urine NAAT FDA approved for men Urethral swab First catch urine 5
6 Gonorrhea Culture provides susceptibility information Endocervical (women) Urethral (men) Rectal Oropharyngeal Conjunctival Many laboratories have met CLIA requirements to perform NAAT on rectal and oropharyngeal specimens Gonorrhea newly scary 6
7 Failure of dual antibiotic therapy in the treatment of gonorrhea June 23, 2016 Correspondence from UK regarding gonorrhea in a MSW infected in Japan Treatment failure after ceftriaxone 500 mg IM plus azithromycin 1 g PO Isolate resistant to ceftriaxone, azithromycin, cefixime, cefotaxime, penicillin, tetracycline, ciprofloxacin Susceptible to spectinomycin Gonorrhea resistance to azithromycin Gonococcal isolates collected at Public Health Seattle & King County STD Clinic : no azithromycin resistance in 292 isolates collected from 263 patients From : 5% of isolates from MSM with reduced susceptibility to azithromycin Clin Infect Dis 2017; 7
8 Gonorrhea preferred treatment Cervix, urethra, rectum, pharynx: Ceftriaxone 250 mg IM in a single dose Plus Azithromycin 1 g orally in a single dose Gonorrhea alternative regimens Preferred (not pharyngeal): Cefixime 400 mg orally in a single dose Plus Azithromycin 1 g orally in a single dose Other possible regimens Gemifloxacin 32o mg PO + Azithromycin 2 g PO Gentamicin 240 mg IM + Azithromycin 2 g PO * National shortage of gemifloxacin continues 8
9 Expedited partner therapy (EPT) As permitted by law EPT gonorrhea CDC recommends for heterosexual partners if inperson treatment impractical Cefixime 400 mg PO + Azithromycin 1 g PO Educational materials Not currently recommended for MSM due to high risk co existing infections (especially HIV) and lack of data 9
10 Chlamydia CDC 2016 STD Surveillance Report Chlamydia Most frequently reported communicable disease Highest rates in those < 25 years Chief complications in women infertility and ectopic pregnancy Screening similar to GC Sexually active women < 25 years annually Women 25 years and older with New sex partner, more than one partner, partner with concurrent partners, partner with STI Sexually active MSM at least annually Urethral, rectal (but not oropharyngeal) depending on sex practices 10
11 Chlamydia Mostly diagnosed by NAAT most sensitive, recommended FDA approved for women Endocervical swab Vaginal swab self or clinician collected, optimal urogenital specimen First catch urine FDA approved for men Urethral swab Urine, optimal urogenital specimen Some laboratories have met CLIA requirements to perform NAAT on rectal and oropharyngeal specimens Some NAATs detect both GC and chlamydia from the same specimen Self collected rectal swabs are acceptable Some NAATs are FDA approved for liquid cytology Chlamydia treatment Recommended regimens Azithromycin 1 g orally as a single dose Doxycycline 100 mg orally twice a day for 7 days Equally efficacious, except azithromycin may be less efficacious for rectal infections Alternative agents include erythromycin, levofloxacin, and ofloxacin EPT same considerations as for GC; use recommended oral regimen 11
12 Chlamydia follow up Test of cure not routinely recommended Reinfection is common Retest women and men diagnosed with chlamydia infection approximately 3 months after treatment, irrespective of partner treatment Trichomonas Most prevalent, non viral STD Racial disparities: female NHANES participants ages 14 49, nationally representative sample, self collected vaginal swab Non Hispanic white women 1.3% Mexican American women 1.8% Non Hispanic black women 13.3% Sutton et al, Clin Infect Dis 2007;45(10): Associated with pre term birth, low birth weight, enhanced HIV transmission 12
13 Trichomonas diagnostic testing Testing primarily in women with vaginal discharge Consider screening in high risk settings lack of data Uncommon in MSM NAAT is highly sensitive and specific In women, can be performed on vaginal, endocervical, and urine specimens Antigen detection and DNA hybridization probe tests are also available Wet mount microscopy is inexpensive and may be convenient Low sensitivity Incidental finding on Pap test not considered diagnostic False positives and negatives Trichomonas treatment Recommended regimens Metronidazole 2 g orally as a single dose OR Tinidazole 2 g orally as a single dose Alternate: metronidazole 500 mg twice daily for 7 days Concurrent treatment of all sex partners 13
14 Trichomonas treatment Resistance is an emerging issue Treatment failure If single dose metronidazole used initially, treat with metronidazole 500 mg twice daily for 7 days If above fails, consider metronidazole or tinidazole 2 g daily for 7 days CDC can facilitate resistance testing High dose tinidazole x 14 days with intravaginal tinidazole can be considered Trichomonas follow up High rate of reinfection among treated women Repeat testing within 3 months recommended, regardless of sex partner treatment Insufficient data regarding retesting in men 14
15 Urethritis male Urethral inflammation Dysuria, urethral pruritis, urethral discharge Steps in work up Evaluate for gonorrhea and chlamydia urine NAAT Confirm inflammation Exam for urethral discharge Gram stain, if available, of urethra secretions look for WBC and Gram negative intracellular diplococci (specific for GC) First void urine to evaluate for pyuria Consider trichomonas in MSW; NAAT not FDA approved but validated by many labs Urethritis male Non gonococcal urethritis (NGU) non specific diagnosis when inflammation present Mycoplasma genitalium accounts for a significant proportion of cases About 30% when persistent or recurrent NAAT is preferred test but not FDA approved, limited availability Doxycycline usually not effective Resistance to azithromycin emerging 15
16 NGU therapy Recommended: Azithromycin 1 g orally in a single dose OR Doxycycline 100 mg twice daily for 7 days Alternate: erythromycin, levofloxacin, ofloxacin all for 7 days Moxifloxacin 400 mg daily for 7 14 days may be successful for M. genitalium Syphilis CDC 2016 STD Surveillance Report 16
17 Syphilis CDC 2016 STD Surveillance Report Syphilis CDC 2016 STD Surveillance Report congenital syphilis cases 17
18 Syphilis increased concern Clusters of ocular syphilis in Seattle and San Francisco 12 cases included in report 11/12 male 10/12 with HIV 4 with persistent visual deficits; 2 legally blind Recent U.S. increase in congenital syphilis 2014 rate highest in more than a decade Increase most marked in West Continued to increase in 2015 MMWR 2015;64(40): MMWR 2015;64(44): Syphilis Stages help guide treatment Primary/secondary and early latent Late latent and latent of unknown duration Neurosyphilis Tertiary without neurosyphilis now rare 18
19 Syphilis Primary ulcer or chancre at infection site Secondary skin rash, mucocutaneous lesions, lymphadenopathy Syphilis Latent no clinical manifestations, diagnosed by serology Early acquired within the preceding year Late or unknown all others Neurosyphilis Early cranial nerve abnormalities, meningitis, CVA, ocular, auditory Late tabes dorsalis and general paresis, usually years after infection Tertiary without neurosyphilis gumma, cardiovascular 19
20 Syphilis diagnosis Treponema pallidum cannot be cultured Early syphilis lesions direct tests not widely available Darkfield microscopy PCR Direct fluorescent antibody test Empirical treatment of early disease when suspicion high Most patients have no lesions Diagnosis is usually by serology Syphilis serologies Non treponemal antibodies React against lipoidal antigens such as cardiolipin Rapid plasma reagin (RPR) Venereal Disease Research Laboratory (VDRL) Treponemal antibodies React against specific T. pallidum antigens Fluorescent treponemal antibody absorbed (FTA ABS) Treponema pallidum particle agglutination (TP PA) Enzyme immunoassays (EIAs) Chemiluminescence immunoassays (CIAs) Microbead immunoassays 20
21 This image cannot currently be displayed. This image cannot currently be displayed. 2/7/2018 Syphilis serologies Non treponemal tests Quantitative reported with a titer Decline with treatment and with time Less specific false positives May be negative in early primary disease Treponemal tests Qualitative positive or negative Usually positive lifelong Ideally, more specific Both types of tests usually required Syphilis testing 21
22 This image cannot currently be displayed. 2/7/2018 Syphilis why switch to reverse testing sequence? Faster Lower cost if high volume No manual pipetting Reduce potential false negatives since no prozone phenomenon May be more sensitive for early syphilis; some tests detect IgM 22
23 Syphilis screening Pregnant women All at first visit Early in 3 rd trimester and at delivery if high risk MSM Annually if sexually active Every 3 6 months if increased risk HIV First evaluation Annually if sexually active Consider more frequently if increased risk Syphilis treatment Primary, secondary, and early latent Benzathine penicillin 2.4 million units IM in a single dose Late latent, latent of unknown duration, tertiary syphilis without neurosyphilis Benzathine penicillin 2.4 million units IM x 3 doses at 1 week intervals Neurosyphilis, including ocular Penicillin G million units per day, administered as 3 4 milliion units IV every 4 hours or as a continuous infusion, for days * National shortage of benzathine penicillin 23
24 Syphilis treatment Alternate regimen doxycycline 100 mg twice daily for 14 days can be considered for primary, secondary and latent disease Pregnancy desensitize and treat with penicillin Syphilis follow up Repeat non treponemal testing for up to 24 months to ensure 4 fold decline in titer Recommend testing schedule varies somewhat based on stage of disease More frequent testing with HIV; otherwise, management of persons with HIV is the same 24
25 This image cannot currently be displayed. 2/7/2018 Syphilis treatment of sex partners Prioritize testing and treatment of contacts to persons with primary, secondary, and early latent disease; usually not infectious after 1 year Presumptive treatment if contact within 90 days of diagnosis Genital herpes HSV 2 more common, especially when recurrent Overall, seroprevalence has decreased in those yrs : 21.2% : 15.5% HSV 1 also causes genital lesions, may account for increasing proportion in young people HSV 1 seroprevalence has decreased in adolescents years : 39% : 30.1% CDC 2016 STD Surveillance Report 25
26 This image cannot currently be displayed. 2/7/2018 Genital herpes Updated December 2016 USPSTF continues to recommend against routine serologic screening for genital HSV infection in asymptomatic adolescents and adults, including those who are pregnant Genital herpes diagnosis Direct testing of lesions PCR most sensitive Cell culture Immunofluorescence assay available but less sensitive Tzanck preparation no longer recommended, lacks sensitivity and specificity Serology Use type specific serology, IgG only Consider with diagnostic uncertainty or to assist with management when partner has genital herpes 26
27 Genital herpes treatment First episode Acyclovir 400 mg three times per day x 7 10 days Acyclovir 200 mg five times per day x 7 10 days Valacyclovir 1 g twice per day x 7 10 days Famciclovir 250 mg three times per day x 7 10 days Genital herpes treatment Recurrent episode Acyclovir 400 mg three times per day x 5 days Acyclovir 800 mg twice per day x 5 days Acyclovir 800 mg three times per day x 2 days Valacyclovir 500 mg twice per day x 3 days Valacyclovir 1 g once per day x 5 days Famciclovir 125 mg twice per day x 5 days Famciclovir 1 g twice per day x 1 day Famciclovir 500 mg once, followed by 250 mg twice daily x 2 days 27
28 This image cannot currently be displayed. This image cannot currently be displayed. This image cannot currently be displayed. 2/7/2018 Genital herpes suppression Reduces recurrences by 70 80% Long term safety and efficacy documented Suppressive therapy decreases transmission Condoms, avoidance of sexual activity with active lesions Recurrences usually diminish over time; consider discontinuation after a period of suppressive therapy Regimens Acyclovir 400 mg twice per day Valacyclovir 500 mg once per day Valacyclovir 1 g once per day Famciclovir 250 mg twice twice per day Emerging STDs Hepatitis C Ebola Zika 28
6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More information5/1/2017. Sexually Transmitted Diseases Burning Questions
Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial
More informationAnswers to those burning questions -
Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department
More informationClinical Practice Objectives
STD Essentials for the Busy Clinician Susan S. Philip, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Director, STD Prevention and Control Services San Francisco Department of Public
More informationSTD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH
STD Essentials for the Busy Clinician Stephanie E. Cohen, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Medical Director, City Clinic San Francisco Department of Public Health Disclosures
More informationSTDs and Hepatitis C
STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk
More informationSexually Transmitted Diseases. Summary of CDC Treatment Guidelines
DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.
More informationSexually Transmitted Disease Treatment Tables
Sexually Transmitted Disease Treatment Tables Federal Bureau of Prisons Clinical Practice Guidelines June 2011 Clinical guidelines are made available to the public for informational purposes only. The
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationEmerging Issues in STDs and Resistance
Emerging Issues in STDs and Resistance Toye H. Brewer, MD Asst. Professor of Clinical Medicine University of Miami School of Medicine Co-Director- Fogarty International Training Program Outline Syphilis-
More informationChapter 11. Sexually Transmitted Diseases
Chapter 11. Sexually Transmitted Diseases General Guidelines Persons identified as having one sexually transmitted disease (STD) are at risk for others and should be screened as appropriate. Partners of
More informationSTDs in HIV Clinical Care: New Guidelines on Treatment and Prevention
STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention Palliative Care Conference Faculty Development Conference August 13, 2015 Steven C. Johnson M.D. Director, University of Colorado HIV/AIDS
More informationLearning Objectives. STI Update. Case 1 6/1/2016
Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe
More informationS403- Update on STIs for the Generalists
S403- Update on STIs for the Generalists Mobeen H. Rathore, MD Professor and Director University of Florida Center for HIV/AIDS Research Education and Service (UF CARES) Chief, Pediatric Infectious Diseases
More informationSexually Transmitted Diseases
Sexually Transmitted Diseases Ina Park, MD, MS California Prevention Training Center University of California San Francisco Dept of Family and Community Medicine Disclosures/Disclaimers No disclosures
More informationWHAT DO U KNOW ABOUT STIS?
WHAT DO U KNOW ABOUT STIS? Rattiya Techakajornkeart MD. Bangrak STIs Cluster, Bureau of AIDS, TB and STIs, Department of Disease Control, MOPH, Thailand SEXUALLY TRANSMITTED INFECTIONS? STIs Infections
More informationSyphilis Treatment Protocol
STD, HIV, AND TB SECTION Syphilis Treatment Protocol CLINICAL GUIDANCE FOR PRIMARY AND SECONDARY SYPHILIS AND LATENT SYPHILIS www.lekarzol.com (4/2016) Page 1 of 8 Table of Contents Description... 3 Stages
More informationClinical Education Initiative ADOLESCENTS AND STDS: CASE STUDIES. Tara Babu, MD
Clinical Education Initiative Support@ceitraining.org ADOLESCENTS AND STDS: CASE STUDIES Tara Babu, MD 2/16/2017 Adolescents and STDs: Case Studies [video transcript] 00:00:08 - Hello, my name is Tia Babu
More informationGenital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham
Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology
More informationThe (likely) New 2010 CDC STD Treatment Guidelines Guideline Development Process. Overview
The (likely) New 2010 CDC STD Treatment Guidelines http://www.cdc.gov/std/treatment Deborah Cohan, MD, MPH University of California, San Francisco San Francisco General Hospital cohand@obgyn.ucsf.edu I
More informationKhalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014
Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine April 2, 2014 E-mail your questions for the presenter to: maphtc@jhsph.edu DISCLOSURES OFF- LABEL USES
More informationUse of Treponemal Immunoassays for Screening and Diagnosis of Syphilis
Use of Treponemal Immunoassays for Screening and Diagnosis of Syphilis Guidance for Medical Providers and Laboratories in California These guidelines were developed by the California Department of Public
More informationDermatologist Venereologist MD, PhD
Vassiliki Mousatou Dermatologist Venereologist MD, PhD Genital warts Genital herpes Syphilis Gonococcal and no gonococcal urethritis HIV Hepatitis B and C Also: Lymphogranuloma venereum and Granuloma
More informationDidactic Series. STD Screening & Management: Syphilis. Christian B. Ramers, MD, MPH
Didactic Series STD Screening & Management: Syphilis Christian B. Ramers, MD, MPH Assistant Medical Director Family Health Centers of San Diego Ciaccio Memorial Clinic 3/26/15 ACCREDITATION STATEMENT:
More informationSyphilis Technical Instructions for Civil Surgeons
National Center for Emerging and Zoonotic Infectious Diseases Syphilis Technical Instructions for Civil Surgeons Joanna J. Regan, MD, MPH, FAAP Medical Officer Medical Assessment and Policy Team Immigrant,
More informationSexually Transmitted Diseases:
Sexually Transmitted Diseases: Diagnosis and Management Department of Internal Medicine, Division of Infectious Diseases University of New Mexico A 21 year old woman comes to your clinic asking to be checked
More informationDisclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.
Disclosures Management of STIs: Challenges in Practice I have no disclosures or conflicts of interest to report. Alison O. Marshall, MSN, FNP-C Associate Professor of Practice & Director of the Family
More informationSTI 2016: Where We Need to Go
STI 2016: Where We Need to Go Gail Bolan, M.D. Director, Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and Prevention Sexually
More informationUpdate on Sexually Transmitted Infections among Persons Living with HIV
Update on Sexually Transmitted Infections among Persons Living with HIV Stephen A. Berry, MD PhD Assistant Professor of Medicine Johns Hopkins University Division of Infectious Diseases Abbreviations and
More informationSTI Indicators by STI
STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients
More information9/9/2015. Began to see a shift in 2012 Early syphilis cases more than doubled from year before
George Walton, MPH, CPH, MLS(ASCP) CM STD Program Manager Bureau of HIV, STD, and Hepatitis September 15, 2015 1 1) Discuss the changing epidemiology of syphilis in Iowa; 2) Explore key populations affected
More informationSexually Transmitted Diseases Treatment Guidelines, 2015
Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 64 / No. 3 June 5, 2015 Sexually Transmitted Diseases Treatment Guidelines, 2015 U.S. Department of Health and Human Services Centers
More informationTrends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017
Trends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017 1 Speaker Disclosure Dr. Woo has disclosed that she has no
More informationOverview. Disclosures. Sexually Transmitted Diseases: What s New in the Guidelines and Beyond?
Sexually Transmitted Diseases: What s New in the Guidelines and Beyond? Susan S. Philip, MD, MPH Director, Disease Prevention and Control Branch Population Health Division San Francisco Department of Public
More informationSyphilis: Screening (USPSFT) Syphilis: Screening. Sexually Transmitted Diseases. Family Medicine Board Review Course. Reference
Sexually Transmitted Diseases Family Medicine Board Review Course March 26, 2012 Ronald H. Goldschmidt, MD Reference Centers for Disease Control and Prevention Guidelines for Treatment of Sexually Transmitted
More informationNovos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]
Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB
More informationSexually Transmitted Infections in the Adolescent Population. Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System
Sexually Transmitted Infections in the Adolescent Population Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System STI in the Adolescent High school students nationwide, 34.2% were
More informationThe Use of a Rapid Syphilis Test with Specimens from an HIV Cluster Investigation in Rural West Virginia
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention The Use of a Rapid Syphilis Test with Specimens from an HIV Cluster Investigation in Rural West Virginia Lara E. Pereira, Ph.D. Centers
More informationPodcast Transcript. Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43
Podcast Transcript Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43 NCTCFP: Welcome to this podcast sponsored by the National
More informationSTD UPDATE 2017 FSACOFP CONVENTION
STD UPDATE 2017 FSACOFP CONVENTION L. Michael Waters, Jr, DO Adjunct Clinical Assistant Professor of Family Medicine LECOM-Bradenton Clinical Assistant Professor of Family Medicine PCOM- Georgia DISCLOSURES
More informationThe Great Imitator Revealed: Syphilis
The Great Imitator Revealed: Syphilis Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles David Geffen School of Medicine Los Angeles, California Learning
More informationUpdate on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH
Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH Division of Infectious Diseases University of Alabama at Birmingham School of Medicine Birmingham, Alabama Outline Syphilis in all its
More informationSTI Treatment Guidelines. Teodora Wi. Training Course in Sexual and Reproductive Health Research
Teodora Wi Geneva, 28 August 2017 STI Treatment Guidelines Teodora Wi Training Course in Sexual and Reproductive Health Research 2017 Twitter @HRPresearch 1 STI treatment guidelines Neisseria gonorrhoeae
More informationSYPHILIS (Treponema pallidum) IMMEDIATE NOTIFICATION STD PROGRAM
SYPHILIS (Treponema pallidum) IMMEDIATE NOTIFICATION STD PROGRAM Event Name: Event Time Period: Clinical Description (CDC 2014) Syphilis 180 days Syphilis is a complex sexually transmitted disease that
More informationStephanie. STD Diagnosis and Treatment. STD Screening for Women. Physical Exam. Cervix with discharge from os
STD Diagnosis and Treatment Ina Park, MD, MS STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center Stephanie 23 year-old female presents for contraception,
More informationALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis
More informationSyphilis in the 21 st Century: Sex, Sores, Science, and Surveillance. Syphilis in Men
Syphilis in the 21 st Century: Sex, Sores, Science, and Surveillance Syphilis in Men Kenneth A. Katz, MD, MSc, MSCE Kaiser Permanente, San Francisco, CA AAD Annual Meeting Washington, D.C. March 2, 2019
More informationSexually Transmitted Infections Angela Farrell MD Dept of Family Medicine University of Iowa
Sexually Transmitted Infections Angela Farrell MD Dept of Family Medicine University of Iowa Objectives Review taking a sexual history Discuss screening, diagnosis, and management of chlamydia, gonorrhea,
More informationLearning Objectives. Syphilis. Lessons. Epidemiology: Disease in the U.S. Syphilis Definition. Transmission. Treponema pallidum
Learning Objectives Syphilis Treponema pallidum 1 Upon completion of this content, the learner will be able to 1. Describe the epidemiology of syphilis in the U.S. 2. Describe the pathogenesis of T. pallidum.
More informationChallenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A
Challenging STD Cases Chris Davis, PA-C University of Utah Clinic 1A Case #1 28 year old HIV + MSM presents for first HIV visit with lesion on glans of penis CD4 count of 3 and viral load of 610,000 Multiple
More informationCLINICAL MANAGEMENT OF STDS
CLINICAL MANAGEMENT OF STDS Diana Torres-Burgos MD, MPH NYC STD/HIV Prevention Training Center STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline Essential components of STD care management Sexual
More informationTimby/Smith: Introductory Medical-Surgical Nursing, 9/e
Timby/Smith: Introductory Medical-Surgical Nursing, 9/e Chapter 62: Caring for Clients With Sexually Transmitted Diseases Slide 1 Epidemiology Introduction Study of the occurrence, distribution, and causes
More informationPublic/Private Partnerships: Intervening in the Spread of Syphilis
Public/Private Partnerships: Intervening in the Spread of Diana Torres-Burgos MD, MPH Gerard Castaneda, BSN Alana Thomas, BS STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline overview Stages
More informationClinical Education Initiative TITLE: UPDATE ON MSM SEXUAL HEALTH. Speaker: Maureen Scahill, MS NP
Clinical Education Initiative Support@ceitraining.org TITLE: UPDATE ON MSM SEXUAL HEALTH Speaker: Maureen Scahill, MS NP 1/25/2017 2/10/2017 Update on MSM Sexual Health [video transcript] 00:00:08 - [Maureen]
More informationManagement of Syphilis in Patients with HIV
Management of Syphilis in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute www.hivguidelines.org Purpose of the Guideline Increase the numbers of NYS
More informationSYPHILIS. The Great Pretender K. Amen Eguakun, MSN, APRN, AAHIVS
SYPHILIS The Great Pretender K. Amen Eguakun, MSN, APRN, AAHIVS Learning Objectives At the end of this presentation, the participants will be able to 1. Describe the epidemiology of syphilis in the United
More informationSEXUALLY TRANSMITTED DISEASES
SEXUALLY TRANSMITTED DISEASES Kaya Süer MD, Near East University Faculty of Medicine Infectious Diseases and Clinical Microbiology True or false 1. Most people with an STD experience painful symptoms.
More informationSyphilis Update: New Presentations of an Old Disease
Syphilis Update: New Presentations of an Old Disease Bradley Stoner, MD, PhD Washington University in St. Louis Disclosure: Bradley Stoner, MD, PhD STDs in the United States Where do we stand right now?
More informationReplaces: 04/13/17. / Formulated: 7/05 SYPHLIS
Effective Date: 81017 Replaces: 041317 Page 1 of 7 POLICY: The Texas Department of Criminal Justice (TDCJ) will identify, test, and manage all offenders with suspected or confirmed syphilis with a uniform
More informationSTD Prevention Among Youth
STD Prevention Among Youth Jody Pierce Glover New Beginnings Emer S. Smith, MPH Maine Center for Disease Control & Prevention In Today s Talk... Maine Learning Results: Education Content Areas Health Behaviors
More informationManagement of Gonorrhea in Adolescents and Adults in the United States
SUPPLEMENT ARTICLE Management of Gonorrhea in Adolescents and Adults in the United States Sarah Kidd 1 and Kimberly A. Workowski 1,2 1 Division of STD Prevention, Centers for Disease Control and Prevention,
More informationSEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5)
SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5) BACTERIAL VAGINOSIS 1 clindamycin cream 2 Cleocin Vaginal Cream 2% vaginal cream Adults: 1 applicatorful at bedtime for 7 days metronidazole
More informationLABORATORY DIAGNOSIS SEXUALLY TRANSMITTED DISEASES
LABORATORY DIAGNOSIS SEXUALLY TRANSMITTED DISEASES LABORATORY MEDICINE COURSE 2004 CLINICAL MICROBIOLOGY SERVICE STD EPIDEMIC- USA TIP OF THE ICEBERG INCIDENCE DISCHARGE Chlamydia - 4 million Gonorrhea
More informationDISCLOSURES LEARNING OBJECTIVES 10/17/2018. NPA Conference Saratoga Srings NY, October Sexually Transmitted Infections: New and Not so New Bugs
Sexually Transmitted Infections: New and Not so New Bugs Melinda S Godfrey MBA, MS, NP University of Rochester Infectious Disease Division Monroe County STD Clinic New York State, STD Center of Excellence
More information10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE OBJECTIVES FOR PHARMACISTS GOAL
DISCLOSURE PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES Dr. Feller does not have any actual or potential conflicts of interest to disclose and will not be discussing
More informationEdward W. Hook, III, M.D.
Challenging Cases Edward W. Hook III M.D. Professor and Director Division of Infectious Diseases University of Alabama at Birmingham And PI, Alabama/North Carolina STD PTC Edward W. Hook, III, M.D. Grant/Research
More informationSex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046)
Sex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046) Kenneth A. Katz, MD, MSc, MSCE Dermatologist, Kaiser Permanente, San Francisco, CA AAD Annual Meeting, San Diego, CA February
More informationNew Guidelines for Detection and Treatment of Sexually Transmitted Infections
UCSF Controversies in Women s health December 8, 2016 San Francisco, CA New Guidelines for Detection and Treatment of Sexually Transmitted Infections Disclosure I am a litigation consultant to a law firm
More informationSex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046)
Sex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046) Kenneth A. Katz, MD, MSc, MSCE Dermatologist, Kaiser Permanente, San Francisco, CA AAD Annual Meeting, Orlando, FL March 4, 2017
More information4/6/17 UNPRECEDENTED HIGH. Shelagh Larson, RNC, WHNP, NCMP
Shelagh Larson, RNC, WHNP, NCMP UNPRECEDENTED HIGH Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annualmore than 1.5 million
More information10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE GOAL
PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES Jade Feller, PharmD PGY-1 Pharmacy Resident Iowa City Veterans Affairs Health Care System November 13, 2018 DISCLOSURE
More informationClinical Guidelines Update (aka Know Your NAATs)
Clinical Guidelines Update (aka Know Your NAATs) WARNING: contains adult themes, sexual references and pictures that may be disturbing! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz
More informationTo view an archived recording of this presentation please click the following link:
To view an archived recording of this presentation please click the following link: http://pho.adobeconnect.com/p16lj8z0qm3/ Please scroll down this file to view a copy of the slides from the session.
More informationWhat s Going On Down There? Prevalent Sexually Transmitted Infections in Adolescents & Young Adults with HIV
What s Going On Down There? Prevalent Sexually Transmitted Infections in Adolescents & Young Adults with HIV Carla London, DNP, CFNP St Jude Children s Research Hospital November 7, 2018 Conflicts and
More informationDisclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None
Disclosures None What s New in the 2015 CDC STD Treatment Guidelines Ina Park, MD, MS California STD/HIV Prevention Training Center UCSF Dept of Family and Community Medicine STD Control Branch California
More informationServices for GLBTQ Youth
Sexual Health Care Services for GLBTQ Youth Gale R Burstein, MD, MPH, FAAP, FSAHM Erie County Commissioner of Health Buffalo, NY Agenda Introduction Epidemiology Sexual health care services for YMSM Sexual
More informationWhat Bugs You? A Sexually Transmitted Infection Review
What Bugs You? A Sexually Transmitted Infection Review KATIE DESIMONE, PHARM.D. Disclosures I have no financial affiliations with any of the products or therapies discussed in this presentation Objectives
More informationSexually transmitted infections
Sexually transmitted infections Dr Caroline CHARLIER-WOERTHER Université Paris Descartes Paris, France Learning objectives Counsel patients about the risk of STD Know how to diagnose and treat a sexuallytransmitted
More informationExtragenital Gonorrhea and Chlamydia among MSM
Extragenital Gonorrhea and Chlamydia among MSM Laura Quilter, MD Infectious Disease and STD PTC Fellow University of Washington Division of Allergy and Infectious Diseases 3/28/2016 uwptc@uw.edu uwptc.org
More informationSusanne Norris Zanto, MPH, MLS (ASCP) CM, SM Montana Public Health Laboratory
Susanne Norris Zanto, MPH, MLS (ASCP) CM, SM Montana Public Health Laboratory Describe the challenges in syphilis diagnostics Present two testing algorithms Non-treponemal test as initial screen Treponemal
More informationRevisions to the Syphilis Surveillance Case Definitions, 2018
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Revisions to the Syphilis Surveillance Case Definitions, 2018 Sarah Kidd, MD, MPH Medical Epidemiologist Division of STD Prevention
More informationSEXUALLY TRANSMITTED INFECTIONS IN ST LOUIS
SEXUALLY TRANSMITTED INFECTIONS IN ST LOUIS Sarah Garwood MD, Assistant Professor of Pediatrics, Washington University Elizabeth Fox MD, Pediatric Resident, St Louis Children s Hospital STDS IN ADOLESCENTS
More informationScreening & Treating Chlamydia in Primary Care. Wednesday, September 21, 2016
Screening & Treating Chlamydia in Primary Care Wednesday, September 21, 2016 We Want To Hear From You! Type questions into the Questions Pane at any time during this presentation Patient-Centered Primary
More informationWhat's the problem? - click where appropriate.
STI Tool v 1.9 @ 16/11/2017 What's the problem? - click where appropriate. Male problems: screening urethral symptoms proctitis in gay men lumps or swellings ulcers or sores skin rash and/or itch Female
More informationSTI Update Including PrEP
STI Update Including PrEP Gordon Liu, M.D, AAHIVS HIV/Hep C Director Latterman Family Health Center UPMC McKeesport Family Medicine Clinical Assistant Professor Department of Family Medicine University
More informationSexually Transmitted Infections in the ER. Sahand Ensafi, CCPA University Health Network
Sexually Transmitted Infections in the ER Sahand Ensafi, CCPA University Health Network WARNING This presentation will contain numerous grotesque images of genitalia. Viewer discretion is advised. No disclosures
More informationShelagh Larson, RNC, WHNP, NCMP
Shelagh Larson, RNC, WHNP, NCMP UNPRECEDENTED HIGH Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annual more than 1.5 million
More informationSexually Transmitted Infections: New Tests, New Guidelines
Sexually Transmitted Infections: New Tests, New Guidelines Michael S. Policar, MD, MPH UCSF Ob, Gyn, and Reproductive Sciences No disclosures for this lecture Value of STI Screening and Testing Benefits
More informationINFECTIOUS SYPHILIS NOTIFICATION FORM
INFECTIOUS SYPHILIS NOTIFICATION FORM This is a Schedule 1, Section C disease notifiable to the Medical Officer of Health under Sections 74 and 74AA of the Health Act 1956 using non-identifiable data.
More informationCategories of STI Screening and Testing Routine screening Population based risk factors Targeted screening Personal behavioral risk factors Contact te
Sexually Transmitted Infections: New Tests, New Guidelines Michael S. Policar, MD, MPH UCSF Ob, Gyn, and Reproductive Sciences No disclosures for this lecture Value of STI Screening and Testing Benefits
More informationWomen s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins
Women s Sexual Health: STI and HIV Screening Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins I have no disclosures! Review most recent rates of STIs and HIV across the
More informationChlamydia Trachomatis and Neisseria Gonorrhoeae. Khalil G. Ghanem, MD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationSTIs: Practical Aspects of Management
STIs: Practical Aspects of Management Dr Heather Young FAChSHM DipPH Christchurch Sexual Health heathery@xtra.co.nz 027 343 4963 Sexually Transmitted Infections BACTERIAL STIs: CHLAMYDIA GONORRHOEA SYPHILIS
More informationCase 1. Case 1. Physical exam
11/13/2012 Case 28 year-old woman Complains of very painful lesions in vulvar area Increasing severity since 4 days Pain aggravated by urination She has a slight fever and also complains of headache and
More informationDISCLOSURES 9/25/2018. Sexually Transmitted Infections: New and Not so New Bugs. Center for Community Practice. Designated by AIDS Institute
Sexually Transmitted Infections: New and Not so New Bugs Melinda S Godfrey MBA, MS, NP University of Rochester Infectious Disease Division Monroe County STD Clinic New York State, STD Center of Excellence
More informationShelagh Larson, RNC, WHNP, NCMP
Shelagh Larson, RNC, WHNP, NCMP UNPRECEDENTED HIGH Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annual more than 1.5 million
More informationGuidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing
Guidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing Recommendations from the an expert consultation meeting held at CDC January 13-15,
More information2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing
2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing Joan M. Chow, MPH, DrPH Surveillance, Epidemiology, Assessment & Evaluation Section Sexually Transmitted Disease Control Branch Division
More informationThe objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and
1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship
More information